Drugmakers Resume COVID-19 Vaccine Trials

SMS
Drugmakers Resume COVID-19 Vaccine Trials
Both Johnson & Johnson and AstraZeneca are starting trials back up again after participants got sick.
SHOW TRANSCRIPT

The race for a COVID-19 vaccine continues for Johnson & Johnson this week.

The company announced it's planning to resume trials today or tomorrow.

Johnson & Johnson's trial was put on hold last week after a study participant became sick.

AstraZeneca has also resumed started U.S. trials again.

They were paused back in early September after one of its a patients became sick as well.

Both companies have contracts with the U.S. to provide a vaccine.